One specific clinical group sees huge surge in GLP-1 prescriptions

• GLP-1 prescriptions for new American mothers increased 24-fold between 2018 and 2025, according to a University of Southern California study.
• The percentage of postpartum women receiving GLP-1 prescriptions grew from 0.8 percent in 2018 to 1.9 percent by early 2025, mostly initiated three to six months after delivery.
• The sharpest increases in prescriptions occurred among mothers diagnosed with type 2 diabetes, gestational diabetes, or pre-pregnancy obesity.
• Researchers warn that safety data regarding GLP-1 medication exposure during breastfeeding remains extremely limited.
• Medical experts currently recommend against taking GLP-1 drugs while nursing due to uncertain risks to infant growth and development.

IN FULL

More new US moms are taking GLP-1 drugs